India's GlaxoSmithKline Pharmaceuticals reported a higher fourth-quarter profit on Tuesday, led by steady demand for its ...

Idiopathic pulmonary fibrosis (IPF) is a chronic lung condition with poor survival times. We previously published a genome-wide meta-analysis of IPF risk across three studies with independent ...

It does not necessarily reflect the view of The Herald. MAYBE it was right that Stevenage were in town to kick the last few drops of hubris out of this underachieving Bolton Wanderers team and ...

Bolton Wanderers' winless run extended to six matches as they ended the season with a draw against Stevenage at the Toughsheet Community Stadium. Second-half substitute Josh Dacres-Cogley had only ...

WANDERERS will be looking to avoid a four-year low going into their final game of the season against Stevenage on Saturday. Steven Schumacher’s injury-hit side picked up a handy point at ...

GSK’s boss has joined other industry chiefs warning the UK and Europe need to ‘do more’ to support the industry or risk losing jobs and investment cash to the US. The pharma giant’s chief ...

Ladies and gentlemen, a very warm welcome to this GSK Q1 2025 Results Call. My name is Constantin Fest, new head of IR at GSK, and I'm delighted to be joined today by Emma Walmsley, Luke Miels and ...

It does not necessarily reflect the view of The Herald. A Labour cabinet member on Stevenage Borough Council has left the party’s group to sit as an independent. Cllr Conor McGrath, who ...

GSK and Smith & Nephew outperformed forecast-beating Barclays today as the FTSE 100 index stayed within reach of a 13th consecutive improvement. London’s top flight stood 5.10 points lower at ...

U.K.-based drugmaker GSK, formerly known as GlaxoSmithKline, has said it is “well positioned” to cope with any financial impact from changes to U.S. tariff rules. The company maintained its financial ...

The American Association for Cancer Research’s annual conference featured updates from several companies on key candidates and assets, including Merck’s Keytruda and GSK’s Jemperli. The American ...

U.S.-listed shares of GSK are gaining in intraday trading Wednesday after the British pharma giant posted better-than-expected first-quarter results and said it was "well positioned" should the ...